Back to Search Start Over

Stratifying the autistic phenotype using electrophysiological indices of social perception

Authors :
Luke Mason
Carolin Moessnang
Christopher Chatham
Lindsay Ham
Julian Tillmann
Guillaume Dumas
Claire Ellis
Claire S. Leblond
Freddy Cliquet
Thomas Bourgeron
Christian Beckmann
Tony Charman
Beth Oakley
Tobias Banaschewski
Andreas Meyer-Lindenberg
Simon Baron-Cohen
Sven Bölte
Jan K. Buitelaar
Sarah Durston
Eva Loth
Bob Oranje
Antonio Persico
Flavio Dell’Acqua
Christine Ecker
Mark H. Johnson
Declan Murphy
Emily J. H. Jones
University of London [London]
Universität Heidelberg [Heidelberg] = Heidelberg University
F. Hoffmann-La Roche [Basel]
King‘s College London
Génétique humaine et fonctions cognitives - Human Genetics and Cognitive Functions (GHFC (UMR_3571 / U-Pasteur_1))
Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)
Centre de recherche du CHU Sainte-Justine / Research Center of the Sainte-Justine University Hospital [Montreal, Canada]
Université de Montréal (UdeM)-CHU Sainte Justine [Montréal]
Radboud University Medical Center [Nijmegen]
Donders Institute for Brain, Cognition and Behaviour
Radboud University [Nijmegen]
Heidelberg University
University of Cambridge [UK] (CAM)
Stockholm Health Care Services (SLSO)
University Medical Center [Utrecht]
Università Campus Bio-Medico di Roma / University Campus Bio-Medico of Rome ( UCBM)
Curtin University [Perth]
Planning and Transport Research Centre (PATREC)
Roche Pharma Research and Early Development [Basel] (pRED)
This project has received funding from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115300, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contribution (E.J.H.J., M.J., T.C., and D.M.), and the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 777394 (E.J.H.J., M.J., T.C., and D.M.). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA and AUTISM SPEAKS, Autistica, SFARI
awards from the Medical Research Council (MR/K021389/1
MR/T003057/1
E.J.H.J., M.J., and T.C.).
European Project: 115300,EC:FP7:SP1-JTI,IMI-JU-03-2010,EU-AIMS(2012)
European Project: 777394,H2020-JTI-IMI2-2016-10-two-stage,AIMS-2-TRIALS(2018)
Source :
Science Translational Medicine, 14, Science Translational Medicine, Science Translational Medicine, 2022, 14 (658), ⟨10.1126/scitranslmed.abf8987⟩, Science Translational Medicine, 14, 658
Publication Year :
2022

Abstract

Contains fulltext : 282637.pdf (Publisher’s version ) (Closed access) Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by difficulties in social communication, but also great heterogeneity. To offer individualized medicine approaches, we need to better target interventions by stratifying autistic people into subgroups with different biological profiles and/or prognoses. We sought to validate neural responses to faces as a potential stratification factor in ASD by measuring neural (electroencephalography) responses to faces (critical in social interaction) in N = 436 children and adults with and without ASD. The speed of early-stage face processing (N170 latency) was on average slower in ASD than in age-matched controls. In addition, N170 latency was associated with responses to faces in the fusiform gyrus, measured with functional magnetic resonance imaging, and polygenic scores for ASD. Within the ASD group, N170 latency predicted change in adaptive socialization skills over an 18-month follow-up period; data-driven clustering identified a subgroup with slower brain responses and poor social prognosis. Use of a distributional data-driven cutoff was associated with predicted improvements of power in simulated clinical trials targeting social functioning. Together, the data provide converging evidence for the utility of the N170 as a stratification factor to identify biologically and prognostically defined subgroups in ASD.

Details

ISSN :
19466234 and 19466242
Volume :
14
Database :
OpenAIRE
Journal :
Science Translational Medicine
Accession number :
edsair.doi.dedup.....667f698ee6fe541b1241ebde2e08c383